It's not officially called Human Genome 2.0. But, key scientists say the research results published Wednesday should re-kindle some of the promise of the Human Genome Project.
One of those key scientists is John Stamatoyannopoloulos of the University of Washington, along with his team of about 40 researchers.
"One of the important hopes here is that this will reinvigorate drug development that’s built around the genome," he says.